Cargando…
PB2655: EVALUATION OF THE EFFICACY AND SAFETY IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH ACQUIRED FACTOR VIII AND IX INHIBITOR
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429658/ http://dx.doi.org/10.1097/01.HS9.0000977304.57128.06 |
| _version_ | 1785090768594010112 |
|---|---|
| author | Koyun, Derya Seval, Güldane Cengiz Civrizbozdağ, Sinem Özcan, Muhit Topçuoğlu, Pervin |
| author_facet | Koyun, Derya Seval, Güldane Cengiz Civrizbozdağ, Sinem Özcan, Muhit Topçuoğlu, Pervin |
| author_sort | Koyun, Derya |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429658 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104296582023-08-17 PB2655: EVALUATION OF THE EFFICACY AND SAFETY IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH ACQUIRED FACTOR VIII AND IX INHIBITOR Koyun, Derya Seval, Güldane Cengiz Civrizbozdağ, Sinem Özcan, Muhit Topçuoğlu, Pervin Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429658/ http://dx.doi.org/10.1097/01.HS9.0000977304.57128.06 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Koyun, Derya Seval, Güldane Cengiz Civrizbozdağ, Sinem Özcan, Muhit Topçuoğlu, Pervin PB2655: EVALUATION OF THE EFFICACY AND SAFETY IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH ACQUIRED FACTOR VIII AND IX INHIBITOR |
| title | PB2655: EVALUATION OF THE EFFICACY AND SAFETY IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH ACQUIRED FACTOR VIII AND IX INHIBITOR |
| title_full | PB2655: EVALUATION OF THE EFFICACY AND SAFETY IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH ACQUIRED FACTOR VIII AND IX INHIBITOR |
| title_fullStr | PB2655: EVALUATION OF THE EFFICACY AND SAFETY IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH ACQUIRED FACTOR VIII AND IX INHIBITOR |
| title_full_unstemmed | PB2655: EVALUATION OF THE EFFICACY AND SAFETY IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH ACQUIRED FACTOR VIII AND IX INHIBITOR |
| title_short | PB2655: EVALUATION OF THE EFFICACY AND SAFETY IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH ACQUIRED FACTOR VIII AND IX INHIBITOR |
| title_sort | pb2655: evaluation of the efficacy and safety immunosuppressive therapy in patients with acquired factor viii and ix inhibitor |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429658/ http://dx.doi.org/10.1097/01.HS9.0000977304.57128.06 |
| work_keys_str_mv | AT koyunderya pb2655evaluationoftheefficacyandsafetyimmunosuppressivetherapyinpatientswithacquiredfactorviiiandixinhibitor AT sevalguldanecengiz pb2655evaluationoftheefficacyandsafetyimmunosuppressivetherapyinpatientswithacquiredfactorviiiandixinhibitor AT civrizbozdagsinem pb2655evaluationoftheefficacyandsafetyimmunosuppressivetherapyinpatientswithacquiredfactorviiiandixinhibitor AT ozcanmuhit pb2655evaluationoftheefficacyandsafetyimmunosuppressivetherapyinpatientswithacquiredfactorviiiandixinhibitor AT topcuoglupervin pb2655evaluationoftheefficacyandsafetyimmunosuppressivetherapyinpatientswithacquiredfactorviiiandixinhibitor |